Loading...
•
Jun 30, 2023
Select Medical Q2 2023 Earnings Report
Announced results for its second quarter and declared a cash dividend.
Key Takeaways
Select Medical Holdings Corporation reported a 5.7% increase in revenue to $1,674.5 million for the second quarter ended June 30, 2023, compared to $1,584.7 million for the same quarter, prior year. Net income increased 38.6% to $91.9 million, and earnings per share increased 44.0% to $0.61.
Revenue increased by 5.7% to $1,674.5 million compared to the same quarter prior year.
Income from operations increased by 31.6% to $159.2 million compared to the same quarter prior year.
Net income increased by 38.6% to $91.9 million compared to the same quarter prior year.
Earnings per common share increased by 44.0% to $0.61 compared to the same quarter prior year.
Revenue by Segment
Forward Guidance
Select Medical is adjusting its 2023 business outlook for revenue, Adjusted EBITDA, and fully diluted earnings per share. Select Medical expects consolidated revenue to be in the range of $6.55 billion to $6.7 billion for the full year of 2023, Adjusted EBITDA to be in the range of $795.0 million to $825.0 million, and fully diluted earnings per share to be in the range of $1.77 to $1.94. Select Medical expects adjusted earnings per share to be in the range of $1.86 to $2.03.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...